To study the effect of platelet count (PC) on bleeding risk and outcome in stroke patients treated with IV thrombolysis (IVT) and to explore whether withholding IVT in PC < 100 × 109/L is supported
To investigate the prognostic value of white blood cell count (WBC) on functional outcome, mortality...
Background: Intravenous thrombolysis (IVT) with (recombinant) tissue plasminogen activator is an eff...
Intravenous thrombolysis (IVT) is the evidence-based treatment of acute ischemic stroke in the first...
To study the effect of platelet count (PC) on bleeding risk and outcome in stroke patients treated w...
To examine whether prior statin use affects outcome and intracranial hemorrhage (ICH) rates in strok...
Intravenous thrombolysis (IVT) for stroke seems to be beneficial independent of the underlying etiol...
Jacek Staszewski,1 Aleksandra Pogoda,1 Kamila Data,1 Klaudia Walczak,1 Maciej Nowocień,2 Emilia Fran...
Objective: To study the safety of off-label IV thrombolysis in patients with very severe stroke (NIH...
Fan Gao,1 Chen Chen,2 Jun Lyu,1 Jie Zheng,1 Xian-Cang Ma,1,3 Xing-Yun Yuan,2 Kang Huo,2 Jian-Feng Ha...
Objective: To study the safety of off-label IV thrombolysis in patients with very severe stroke (NIH...
Background and Purpose—Antiplatelets (APs) may increase the risk of symptomatic intracerebral hemorr...
Thrombolysis is one of the proven potential treatments for the management of acute ischemic stroke. ...
Objective To investigate the prognostic value of white blood cell count (WBC) on functional outcome,...
The science of metric-based patient stratification for intravenous thrombolysis, revolutionized by t...
9/L is supported. 9/L. Unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals (CIs)...
To investigate the prognostic value of white blood cell count (WBC) on functional outcome, mortality...
Background: Intravenous thrombolysis (IVT) with (recombinant) tissue plasminogen activator is an eff...
Intravenous thrombolysis (IVT) is the evidence-based treatment of acute ischemic stroke in the first...
To study the effect of platelet count (PC) on bleeding risk and outcome in stroke patients treated w...
To examine whether prior statin use affects outcome and intracranial hemorrhage (ICH) rates in strok...
Intravenous thrombolysis (IVT) for stroke seems to be beneficial independent of the underlying etiol...
Jacek Staszewski,1 Aleksandra Pogoda,1 Kamila Data,1 Klaudia Walczak,1 Maciej Nowocień,2 Emilia Fran...
Objective: To study the safety of off-label IV thrombolysis in patients with very severe stroke (NIH...
Fan Gao,1 Chen Chen,2 Jun Lyu,1 Jie Zheng,1 Xian-Cang Ma,1,3 Xing-Yun Yuan,2 Kang Huo,2 Jian-Feng Ha...
Objective: To study the safety of off-label IV thrombolysis in patients with very severe stroke (NIH...
Background and Purpose—Antiplatelets (APs) may increase the risk of symptomatic intracerebral hemorr...
Thrombolysis is one of the proven potential treatments for the management of acute ischemic stroke. ...
Objective To investigate the prognostic value of white blood cell count (WBC) on functional outcome,...
The science of metric-based patient stratification for intravenous thrombolysis, revolutionized by t...
9/L is supported. 9/L. Unadjusted and adjusted odds ratios (ORs) with 95% confidence intervals (CIs)...
To investigate the prognostic value of white blood cell count (WBC) on functional outcome, mortality...
Background: Intravenous thrombolysis (IVT) with (recombinant) tissue plasminogen activator is an eff...
Intravenous thrombolysis (IVT) is the evidence-based treatment of acute ischemic stroke in the first...